Qihan Biotech Funding: $75M Raised, Series B (2023)
Qihan Biotech is based in Hangzhou, China. It has raised $75M in total funding. Latest round: Series B.
Qihan Biotech funding overview
Qihan Biotech is based in Hangzhou, China. Qihan Biotech has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2023. The round record for Qihan Biotech runs through 2023; nothing later has been disclosed. Investors on record include Jinkong Capital, Alta Partners, ARCH Venture Partners, Sequoia Capital China, CMB International Capital, Legend Star and 4 others. 10 distinct backers are named across the disclosed rounds.
Qihan Biotech at a glance
Total raised
$75M
Latest round
Series B
Latest round date
September 2023
Headquarters
Hangzhou, China
Notable investors
Jinkong Capital, Alta Partners, ARCH Venture Partners, Sequoia Capital China, CMB International Capital, Legend Star, Xinyi Biology, BC Capital
Frequently asked about Qihan Biotech funding
How much has Qihan Biotech raised?
Qihan Biotech has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Qihan Biotech?
Jinkong Capital, Alta Partners, ARCH Venture Partners, Sequoia Capital China, CMB International Capital, Legend Star are named among the investors backing Qihan Biotech.
What was the latest Qihan Biotech funding round?
The most recent disclosed round is a Series B, announced in September 2023.
Where is Qihan Biotech based?
Qihan Biotech is based in Hangzhou, China.
When did Qihan Biotech last raise?
The last disclosed Qihan Biotech round closed in September 2023 at Series B.
Qihan Biotech totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hangzhou below to benchmark round size and investor mix.
